Abdallah Roukain Heba Alwan Massimo Bongiovanni Gerasimos P Sykiotis Peter A Kopp
10.3389/fendo.2021.794988
Front Endocrinol (Lausanne)
2022 Jan 31;12:794988.
rankl calcimimetics denosumab hypercalcemia parathyroid carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/35173680/
Denosumab / therapeutic use Hypercalcemia / drug therapy Parathyroid Neoplasms / complications
Denosumab / therapeutic use Hypercalcemia / drug therapy Parathyroid Neoplasms / complications Case Reports Review Aged, 80 and over Calcium / blood Female Humans Hypercalcemia / etiology Denosumab Calcium
PMC8842631
35173680
Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report
2022